Skip to content
Compounding for the Veterinary Patient | 6-hour ACPE-accredited home study
Compounding for the Veterinary Patient is a 6-hour ACPE-accredited home study designed for pharmacists and pharmacy technicians who want to strengthen their knowledge of veterinary compounding. This self-paced program explores the regulatory, clinical, and practical considerations involved in preparing customized medications for animal patients while supporting safe and compliant pharmacy practice.
Participants will review veterinary compounding regulations, extra-label drug use, office-use compounding, patient-specific prescription requirements, and current FDA guidance affecting veterinary pharmacy practice. The program also examines USP General Chapter <795>, including personnel training, documentation, quality assurance, quality control, beyond-use dating, and facility requirements for nonsterile compounding.
Additional modules focus on veterinary dosage forms, pharmaceutical calculations, flavoring strategies, veterinary pharmacology, species-specific therapeutic considerations, toxicology, and practical compounding techniques used to improve medication administration and patient compliance. Participants will also explore commonly compounded veterinary medications, specialized compounding vehicles, and real-world examples that support individualized treatment across a variety of animal species.
Whether you are new to veterinary compounding or looking to expand your expertise, this home study provides practical knowledge that can be applied immediately in pharmacy practice.
Q: Who should complete this home study?
Pharmacists, pharmacy technicians, student pharmacists, and pharmacy professionals interested in veterinary compounding, USP <795>, nonsterile compounding, and medication safety for animal patients.
Q: Will I earn CE credit?
Yes. This activity provides 6 contact hours (0.6 CEU) of ACPE-accredited continuing education for pharmacists and pharmacy technicians.
Expand your veterinary compounding knowledge with this flexible home study covering regulations, USP <795>, pharmacology, dosage forms, and medication safety.
What participants said:
- “The material was comprehensive and easy to understand.”
- “Thorough review of the history of regulations and how this shaped compounding regulations.”
- “Excellent presentation. Clear explanations, practical examples, and useful information on veterinary compounding and dosage forms.”
Registration is below
Note: It is not necessary to create a Lecture Panda account to register for this home study.
The American College of Apothecaries (ACA) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACA has accredited this knowledge-based program for 6 contact hours (0.6 CEU) of continuing education credit for pharmacists and pharmacy technicians.
Register of Historic Places and is world-famous for its five resident Mallard ducks, who march daily through the lobby at 11am and 5pm.
Martha M. Rumore, PharmD, Esq, MS, LLM, FAPhA is a pharmacist-attorney in Frier Levitt’s Life Sciences Department. She is also a registered patent attorney and leads the firm’s Intellectual property team. She has broad and in-depth healthcare and regulatory experience. Her practice focuses on intellectual property (patents, trademarks, copyrights, trade secrets) and healthcare law, Food, Drug, Device & Cosmetic law (all facets-483s to clinical trials to registrations and product approval), pharmacy law and regulatory issues, 503A/503B compounding, Board of Pharmacy (licensing and disciplinary matters), PBM audits, and DSCSA supply chain compliance. Dr. Rumore has over 25 years of health-system, pharmaceutical industry, and law firm experience in the area of Food, Drug & Cosmetic Law, and pharmaceutical intellectual property Dr. Rumore is fluent in cGMPs, GCPs, writing and reviewing Clinical Trial Agreements (CTAs), Investigator brochures, manuscripts, labeling & advertising review, NDAs, study reports, and documents for regulatory submissions. She often prepares legal memoranda on healthcare/FDA matters and conducts Mock State Board of Pharmacy and FDA inspections for compounding pharmacies. Dr. Rumore has practiced both pharmacy and law. She has actual experience as a compounding pharmacist. She regularly counsels on Section 503A and state-specific compounding requirements, assesses compounding practices for state and federal regulatory compliance, including USP 797/795/800, medical necessity documentation, advertising & promotion, reimbursement issues, infrastructure, and preparing compounding policies and procedures that provide clear guidelines, standards, and training for staff. Previously, she was at the Director level in Drug Regulatory Affairs/Compliance in the pharmaceutical industry and hospital pharmacy. She taught Pharmacy Law, Drug Regulatory Affairs, and Food Drug & Cosmetic Law at several New York Colleges of Pharmacy and currently teaches Food, Drug & Cosmetic Law at Maurice A. Deane School of Law at Hofstra University. She is a frequent lecturer and has over 200 publications and presentations.
